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Abstract
Background: Disaccharide Intolerance Type I (Mendelian Interance in Man database: *222900) is
a rare inborn error of metabolism resulting from mutation in sucrase-isomaltase (Enzyme
Catalyzed 3.2.1.48). Usually, infants with SI deficiency come to attention because of chronic
diarrhea and nutritional evidence of malabsorption.
Case Presentation: We describe an atypical presentation of this disorder in a 10-month-old
infant. In addition to chronic diarrhea, the child displayed severe and chronic hypercalcemia, the
evaluation of which was negative. An apparently coincidental right orbital hemangioma was
detected. Following identification of the SI deficiency, an appropriately sucrose-restricted, but
normal calcium diet regimen was instituted which led to cessation of diarrhea, substantial weight
gain, and resolution of hypercalcemia.
Conclusions:  This case illustrates that, similar to congenital lactase deficiency (Mendelian
Interance in Man database: *223000, Alactasia, Hereditary Disaccharide Intolerance Type II),
hypercalcemia may complicate neonatal Sucrase-Isomaltase deficiency. Hypercalcemia in the
presence of chronic diarrhea should suggest disaccharide intolerance in young infants.
Background
Sucrase-isomaltase (SI, EC 3.2.1.48) is an enterocyte-spe-
cific small intestine brush-border membrane disacchari-
dase. It is required for hydrolysis of dietary sucrose and
some starches. Because absorption cannot take place until
monosaccharides are produced, SI deficiency leads to in-
creased luminal disaccharides and consequent osmotic di-
arrhea. Although generally thought to have a later
presentation [1] than other primary intestinal malabsorp-
tion syndromes, recent reports of infants with SI deficien-
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cy indicate the existence of an early onset form
(presentation of diarrhea at 2–16 weeks) that is compli-
cated by severe malnutrition [2]. Starnes and Walsh [3]
observed renal calculi in two adults with sucrase deficien-
cy, but neither patient had evidence of hypercalcemia. In
contrast, hypercalcemia frequently complicates congeni-
tal lactase deficiency [4]. The present case illustrates the
occurrence of hypercalcemia and nephrocalcinosis as a
clinically significant complication of SI deficiency in an
infant and suggests that common mechanisms may lead
to hypercalcemia in both SI and congenital lactase defi-
ciency.
Case Presentation
The patient was a 10 month old caucasian female infant
presenting with failure to thrive (FTT), metabolic acidosis,
and hypercalcemia. She was the product of a term uncom-
plicated pregnancy in a 31-year-old and delivered without
complications. She had been growing well and thriving
until weaned from breast milk to formula at age 4 months
when she began to have frequent stools and poor weight
gain. Formula and diet changes were attempted without
improvement. She was seen by a pediatric gastroenterolo-
gist and underwent colonoscopy, a biopsy from which
showed eosinophilic inflammation. Upper GI tract endos-
copy was interrupted because of sedation problems. She
was treated with glucocorticoids and her formula was
changed to Neocate (49 mg Ca/100 mL) with some initial
improvement. The glucocorticoids were discontinued at
age 9 months but she still gained weight poorly; routine
chemistry analyses showed evolving hypercalcemia (out-
patient calcium peak 13.7 mg/dL, Figure 1) and persistent
metabolic acidosis. She was admitted to the hospital for
Figure 1
Course of hypercalcemia and response to dietary interventionBMC Pediatrics 2002, 2 http://www.biomedcentral.com/1471-2431/2/4
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evaluation and treatment of hypercalcemia, FTT, and met-
abolic acidosis.
Other than skin changes consistent with wasting, her ex-
amination was benign. There was no abnormal flatus or
bloating, but there had been intermittent blood in the
stool with some mucous. Laboratory studies are shown in
Table 1. The intact parathyroid hormone (PTH) was ap-
propriately suppressed to 6 pg/mL with concomitant se-
rum calcium of 13.8 mg/dL and ionized calcium (Ca2+)
1.98 mmol/L (normal 1.20–1.38); other pertinent labora-
tory values included: phosphorus 5.7 mg/dL; magnesium
2.6 mg/dL; alkaline phosphatase 79 IU/L; PTH-related
peptide (PTH-rp) appropriately undetectable at <0.2
pmol/L (normal < 2.8); 25-hydroxy Vitamin D 16 ng/mL
(reference lab normal range for age 3–17 years = 13–67);
and 1,25-dihydroxy Vitamin D level 32 pg/mL (reference
lab normal range for age 3–17 years = 27–71). The urine
calcium was 11.9 mg/dL with urine creatinine < 10 mg/
dL. Renal ultrasound demonstrated nephrocalcinosis. The
hemi-skeletal bone age was interpreted to be delayed to
that of a 3–6 month old. Stools were positive for leuko-
cytes and trace reducing substances. Normal karyotype
and normal fluorescent in-situ hybridization (FISH) for
the elastin gene locus on chromosome 7 (46, XX, negative
ELN 7q11.23) along with a negative echocardiogram
helped exclude Williams syndrome. She initially was
treated with intravenous normal saline followed by furo-
semide with only transient improvement. Recurrent hy-
percalcemia prompted a 3-day course of intravenous
pamidronate (0.5 mg/kg per dose) leading to sustained
high-normal serum calcium (Figure 1). She was dis-
charged home. She was empirically treated with Polyci-
tra™ for the persistent metabolic acidosis, but on-going
FTT prompted reevaluation.
Table 1: Initial admission and follow up studies of case report.
Metabolite Admission #1 Age 9 
mos
Admission #2 Age 10 
mos
Age 17 mos
Na (mmol/L) 144 140 139
K (mmol/L) 3.9 5.7 4.1
Cl (mmol/L) 103 101 103
CO2 (mmol/L) 22 19 24
BUN (mg/dL) 18 32 14
Creatinine (mg/dL) 0.4 0.2 0.3
Glucose (mg/dL) 96 69 92
AST (U/L) 33 73
ALT (U/L) 9 24
Alkaline Phosphatase (U/L) 79 152
LDH (U/L) 928 748
Pre-albumin (g/dL) 20.0 18.1
Total Protein (g/dL) 8.0 7.9
Albumin (g/dL) 4.5 5.2
Calcium (mg/dL) 13.8 10.9 10.3
Ca 2+ (mmol/L) 1.98 1.44
Phosphorus (mg/dL) 5.7 7.7 5.1
PTH (pg/mL) 6 10
PTH-rp (pmol/L) <0.2
VIP (ng/mL) < 5
Urine Ca/Cr 11.9/<10 2.8 0.36
25-hydroxy Vitamin D (ng/mL) 16 16
1,25-dihydroxy Vitamin D (pg/mL) 32 47




Vitamin A (µg/dL) 33
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At time of second admission the infant was taking Neo-
cate supplemented with 5 jars of baby food fruits per day
plus Polycitra™. Gross motor development was delayed
but other developmental axes were intact. Family history
was significant for Hashimoto's thyroiditis in the mother,
maternal aunt, and maternal grandfather. The parents
were both of European ethnic origin and there was no
consanguinity. Physical examination showed an alert,
nondysmorphic infant with severe reduction in muscle
mass and subcutaneous fat. Frequent loose watery stools
were noted. A skeletal survey showed striking linear bone
density increase in the epiphyses in an area adjacent to the
growth plate (Figure 2A). Follow up admission laboratory
studies are shown in Table 1. Specifically, the calcitonin
was 9.9 pg/mL (normal < 12) and the Vitamin A concen-
tration was 33 µg/dL (20–43). The urine calcium was 11.1
mg/dL and calcium/creatinine ratio of 2.8. EKG showed a
normal QTc. Renal ultrasound confirmed nephrocalcino-
sis (Figure 2B). Upper endoscopy with biopsy revealed ar-
eas of mild focal chronic inflammatory cells in the
stomach. Colonoscopy showed no bowel wall inflamma-
tion but copious watery stool. Stool sodium was 17
mmol/L.
The persistence of hypercalcemia with diarrhea prompted
a nuclear medicine scan with 1.5 mCi of 111indium pen-
tetreotide to pursue a possible paraneoplastic process [5]
which showed uptake in the right orbital region. A head
CT and MRI demonstrated an infiltrating lesion in the
right orbit along the inferior and lateral compartment of
the orbit involving the intra- and extra-coronal space.
There was no obvious lytic change or periostosis; howev-
er, there were flow voids consistent with a vascular malfor-
mation. No abnormalities in extraocular movements,
globe, or retina were observed. These findings were inter-
preted as consistent with a benign orbital hemangioma.
Serial follow up studies confirm that the lesion is not
growing; indeed there is evidence of fatty involution.
Small bowel biopsies taken at the time of endoscopy re-
vealed: lactase 34.6 µM/min/g (24.5 +/- 18, abnormal less
than 15), sucrase 0 µM/min/g (54.4 +/- 25.4, abnormal
less than 25), maltase 22.7 µM/min/g (160.8 +/- 52.8, ab-
normal less than 100) leading to the diagnosis of sucrase-
isomaltase deficiency. Sucrose free diet with Sucraid™ en-
zyme replacement was prescribed followed by changing
feeds to 3232A base formula with supplemental anhy-
Figure 2
Diagnostic imaging studies. A. Increased bone density in area adjacent to distal femoral growth plate; B. renal ultrasound dem-
onstrating left medullary nephocalcinosisBMC Pediatrics 2002, 2 http://www.biomedcentral.com/1471-2431/2/4
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drous dextrose (Ca 94 mg/100 mL) resulting in a prompt
cessation of diarrhea. Urine calcium/creatinine ratio de-
creased to 0.58. Her weight has steadily improved (Figure
3). Residual muscle weakness in the lower extremities is
being treated with physical therapy.
Causes of hypercalcemia in infancy
An extensive evaluation of our patient failed to identify
any abnormality in calcium regulation. It should be em-
phasized that our patient demonstrated nephrocalcinosis
prior to alkalinization with Polycitra™ to combat her met-
abolic acidosis. Urine alkalinization is a common strategy
to treat urate and cysteine renal stones. Animal and pre-
liminary human studies suggest acid-phosphate replace-
ment (vs. neutral-phosphate therapy) is of equal benefit
and does not perturb calcium/phosphorus metabolism in
children with phosphate-wasting rickets [6]. Infants with
hypercalcemia may have no obvious symptoms, but con-
stitutional symptoms such as poor appetite, irritability,
vomiting, FTT, or occasionally seizures may occur [7].
Classically, hypercalcemia leads to increased urine output
and diminished stool frequency. Physical signs may in-
clude hypotonia, dehydration, and bradycardia. Labora-
tory abnormalities can include short QTc and elevated
creatinine. Increased urinary calcium is an expected com-
pensatory response with associated increased risk of renal
calculi. The differential diagnosis of hypercalcemia in in-
fants includes hyperparathyroidism, familial hypocalciu-
ric hypercalcemia, hypervitaminosis, paraneoplastic
processes, and Williams syndrome.
Hyperparathyroidism may be either sporadic or familial
arising from either adenoma or parathyroid hyperplasia.
Familial hyperparathyroidism may be confined to parath-
yroid adenoma (HRPT1 #145000) or may involve the
broader endocrine disturbances of multiple endocrine ne-
oplasia Types I (#131100) and IIA (#171400). MENI re-
sults from mutations in menin, a regulator of TGFβ
signaling in a variety of tissues [8]. MENIIA results form
mutations in RET a cell surface growth factor receptor with
intrinsic tyrosine kinase activity [9]. Familial hypocalciu-
ric hypercalcemia (#145980), generally autosomal domi-
nant and caused by mutations in the renal calcium
sensing receptor [10,11], is excluded rather easily based
on urinary calcium levels of the patient and parents.
Both hypervitaminoses D and A are potential causes of hy-
percalcemia. Prolonged feeding with over fortified milk or
vitamin preparations has been reported as sources of ex-
cess intake of vitamin D. Abnormal vitamin D metabo-
lism resulting from inflammatory diseases such as
sarcoidosis or tuberculosis or as seen in neonatal fat
necrosis are additional potential causes, albeit highly un-
likely in young infants [12]. The mechanism is thought to
be due to increased 1á-hydroxylase activity leading to in-
creased production of 1,25-dihydroxy Vitamin D.
While neoplasia with osseous metastasis is a potential
cause of hypercalcemia, tumors may also secrete materials
such as PTH-rp or other osteoclast-activating factors, cy-
tokines, or other growth factors that modulate bone re-
modeling leading to calcium adsorption from bone.
Chronic immobilization can also lead to enhanced bone
resorption.
Williams syndrome is a well described birth defect com-
plex characterized by FTT, branch pulmonary artery sten-
osis, supravalvular aortic stenosis, dysmorphic facies,
mental retardation, and infantile hypercalcemia. Williams
syndrome results from a constitutional deletion in chro-
mosome 7q11.23 [13]. The cause of hypercalcemia asso-
ciated with Williams syndrome is not well understood but
has been postulated to be associated with enhanced intes-
tinal absorption of calcium. The presence or absence of
Figure 3
Growth response to dietary interventionBMC Pediatrics 2002, 2 http://www.biomedcentral.com/1471-2431/2/4
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significant hypercalcemia does not correlate with the de-
letion size [14].
Sucrase-isomaltase deficiency
Sucrase-isomaltase deficiency is a rare autosomal recessive
disorder in which there is complete absence of sucrase and
most of the maltase digestive activity. The usual presenta-
tion generally is at weaning from breast milk when infants
are first exposed to the offending carbohydrates [15–17].
Upon ingestion of disaccharides and oligosaccharides, the
failure to breakdown sucrose into fructose and glucose re-
sults in an osmotic-fermentative diarrhea. Occasional pa-
tients may come to attention in late childhood or
adulthood but careful history often indicates that symp-
toms have appeared earlier [18,19]. The mainstay of treat-
ment is dietary restriction of sucrose-containing foods.
Effective enzyme replacement with whole yeast cells has
been reported [20]. Purified yeast enzyme, sacrosidase, is
a highly effective adjunct to dietary restriction [21].
The enzyme itself is composed of 1827 amino acids en-
coded by a 3364 bp mRNA. The gene locus has 30 exons
spanning 106.6 kB. Pro-SI is anchored in the membrane
by a 20 amino acid membrane-spanning segment. This is
followed by a 22 amino acid stalk on which sit the 2 glob-
ular catalytic domains. The catalytic domains are similar
to one another (41% amino acid identity) indicating that
they have arisen by duplication and divergence [22]. One
estimate indicated a 2% mutant heterozygote frequency in
European Americans [23] but, given the rarity of diag-
nosed SI deficiency, this seems high. Sucrase deficiency
may be especially common in indigenous Greenlanders
(estimated 5%) and is accompanied most often by lactase
deficiency [24,25]. Initial studies demonstrated that most
SI mutations result in lack of enzyme protein (i.e. null
mutation) [26]. Mutation may alter the post-translational
processing of the enzyme only for the asparagines-linked
high-mannose groups but not the mature oligosaccha-
rides. The resulting enzyme is both mislocalized and un-
stable [27]. Another mutation, Q1098P, was found to
cause retention of SI in the transport pathway between the
endoplasmic reticulum and Golgi apparatus [28]. An un-
usual mutation, Q117R, that alters the structure close to
the O-glycosylated stalk domain, leads to random distri-
bution of the enzyme to both the apical and basolateral
cell membranes [29]. An unusual human mutation that
causes SI to be secreted rather than retained in the plasma
membrane demonstrates that the enzyme is required to be
at the enterocyte cell surface [30].
Disaccharidase deficiency and hypercalcemia
A single case report potentially relates SI deficiency with
disturbance of calcium metabolism. In that study, two
adults presented with renal calculi and nephrocalcinosis
[3]. Lactase deficiency may give rise to metabolic bone dis-
ease [31]. More pertinently, Saarela et al described 7 of 10
infants with congenital lactase deficiency who had hyper-
calcemia at the time of initial presentation [4]. Five of
these 7 infants had medullary nephrocalcinosis. The
mechanism by which congenital lactase deficiency induc-
es hypercalcemia is uncertain. There may be roles for
chronic metabolic acidosis and dehydration in promoting
both increased bone mobilization of calcium and thus in-
creasing the risk of renal deposition. Non-hydrolyzed lac-
tose may also exert a direct enhancing effect on calcium
absorption in the ileum. In other conditions with chronic
diarrhea, such as inflammatory bowel disease, renal
stones have been composed of calcium phosphate or
oxalate [32]. Alternatively, it is possible that both SI and
lactase are connected mechanistically to intestinal calci-
um homeostasis through molecular interactions with cal-
cium transporters. In this regard, SI, lactase, and the
receptor for 1,25 OH-VitD3 (VDR) share transcriptional
regulation through the homeodomain transcription fac-
tor CDX2 [33,34]. The possibility that SI or lactase defi-
ciency could cause secondary up-regulation of VDR awaits
exploration in cell culture or animal models.
Conclusions
We conclude that SI deficiency should be added to the list
of disorders that can cause infantile hypercalcemia and
particularly may be considered when accompanied by FTT
and watery diarrhea. In addition, infants with SI deficien-
cy should have careful monitoring of serum calcium. Pro-
longed periods of diet noncompliance may increase the
risk of chronic renal disease secondary to nephrocalcino-
sis. Infants presenting with persistent, watery diarrhea
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